Its key to stick to the treatment plan and adjust the dose as needed
It activates the HGF/c-Met pathway in the brain, driving the formation of new synaptic connections a process called synaptogenesis
therefore, researchers warn that it carries the identical theoretical risk of exacerbating oncological conditions by promoting new blood vessel formation within tumor microenvironments, rendering it unsafe for use in patients with a history of cancer
Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM
for diabetic neuropathy, a common protocol is daily IV infusions for 2-4 weeks as an initial therapy
Cosmetic chemists formulating products routinely separate copper peptide and vitamin C ingredients because stability testing shows degradation when combined